Calpain 2-dependent IκBα degradation mediates CPT-11 secondary resistance in colorectal cancer xenografts (Q42497081)

1 November 2017

title

Calpain 2-dependent IκBα degradation mediates CPT-11 secondary resistance in colorectal cancer xenografts (English)

1 reference

1 November 2017

1 reference

1 reference

1

Nina Fenouille

1 reference

1 November 2017

Sebastien Grosso

2

1 reference

1 November 2017

Su Yunchao

3

1 reference

1 November 2017

Didier Mary

4

1 reference

1 November 2017

Rodolphe Pontier-Bres

5

1 reference

1 November 2017

Véronique Imbert

6

1 reference

1 November 2017

Dorota Czerucka

7

1 reference

1 November 2017

François-Xavier Caroli-Bosc

8

1 reference

1 November 2017

Jean-François Peyron

9

1 reference

1 November 2017

Patricia Lagadec

10

1 reference

1 November 2017

publication date

9 February 2012

1 reference

1 November 2017

1 reference

1 November 2017

volume

227

1 reference

1 November 2017

issue

1

1 reference

1 November 2017

page(s)

118-129

1 reference

Irinotecan in the treatment of colorectal cancer: clinical overview

1 November 2017

cites work

1 reference

Gene expression signature in advanced colorectal cancer patients select drugs and response for the use of leucovorin, fluorouracil, and irinotecan

21 January 2018

1 reference

Irinotecan: mechanisms of tumor resistance and novel strategies for modulating its activity

21 January 2018

1 reference

Pharmacological targeting of NF-kappaB potentiates the effect of the topoisomerase inhibitor CPT-11 on colon cancer cells.

21 January 2018

1 reference

Targeting NF-kappaB activation via pharmacologic inhibition of IKK2-induced apoptosis of human acute myeloid leukemia cells.

21 January 2018

1 reference

Inducible nuclear factor-kappaB activation contributes to chemotherapy resistance in gastric cancer

21 January 2018

1 reference

Potentiation of chemotherapeutic agents following antagonism of nuclear factor kappa B in human gliomas

21 January 2018

1 reference

How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex

21 January 2018

1 reference

Activators and target genes of Rel/NF-kappaB transcription factors

21 January 2018

1 reference

Signals from within: the DNA-damage-induced NF-kappaB response

21 January 2018

1 reference

Signalling loops and linear pathways: NF-kappaB activation in response to genotoxic stress

21 January 2018

1 reference

Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei

21 January 2018

1 reference

An open-access long oligonucleotide microarray resource for analysis of the human and mouse transcriptomes.

21 January 2018

1 reference

Live Staphylococcus aureus and bacterial soluble factors induce different transcriptional responses in human airway cells

21 January 2018

1 reference

limmaGUI: a graphical user interface for linear modeling of microarray data

21 January 2018

1 reference

Mediante: a web-based microarray data manager

21 January 2018

1 reference

Tumor necrosis factor-alpha-inducible IkappaBalpha proteolysis mediated by cytosolic m-calpain. A mechanism parallel to the ubiquitin-proteasome pathway for nuclear factor-kappab activation

21 January 2018

1 reference

The effects of calpain inhibition on IkB alpha degradation after activation of PBMCs: identification of the calpain cleavage sites

21 January 2018

1 reference

Development of rituximab-resistant lymphoma clones with altered cell signaling and cross-resistance to chemotherapy.

21 January 2018

1 reference

Clinical determinants of response to irinotecan-based therapy derived from cell line models

21 January 2018

1 reference

Overexpression of phosphoserine aminotransferase PSAT1 stimulates cell growth and increases chemoresistance of colon cancer cells

21 January 2018

1 reference

Heat shock protein 27 is associated with irinotecan resistance in human colorectal cancer cells

21 January 2018

1 reference

Copper-transporting P-type ATPase, ATP7A, confers multidrug resistance and its expression is related to resistance to SN-38 in clinical colon cancer.

21 January 2018

1 reference

Enhanced sensitivity to irinotecan by Cdk1 inhibition in the p53-deficient HT29 human colon cancer cell line

21 January 2018

1 reference

Pregnane X Receptor (PXR) expression in colorectal cancer cells restricts irinotecan chemosensitivity through enhanced SN-38 glucuronidation.

21 January 2018

1 reference

Increased topoisomerase IIalpha expression in colorectal cancer is associated with advanced disease and chemotherapeutic resistance via inhibition of apoptosis

21 January 2018

1 reference

Genome-wide expression analysis of therapy-resistant tumors reveals SPARC as a novel target for cancer therapy

21 January 2018

1 reference

Heparin-binding EGF-like growth factor is an early response gene to chemotherapy and contributes to chemotherapy resistance

21 January 2018

1 reference

S100A10/p11: family, friends and functions

21 January 2018

1 reference

Annexin A2 Mediates Up-regulation of NF-κB, β-catenin, and Stem Cell in Response to Progastrin in Mice and HEK-293 Cells

21 January 2018

1 reference

Overcoming acquired resistance to TRAIL by chemotherapeutic agents and calpain inhibitor I through distinct mechanisms

21 January 2018

1 reference

Bik/NBK accumulation correlates with apoptosis-induction by bortezomib (PS-341, Velcade) and other proteasome inhibitors

21 January 2018

1 reference

Proteasome inhibitor PS-341 (bortezomib) induces calpain-dependent IkappaB(alpha) degradation

21 January 2018

1 reference

The calpain system and cancer.

21 January 2018

1 reference

Complex formation and submembranous localization of annexin 2 and S100A10 in live HepG2 cells

21 January 2018

1 reference

Nuclear Factor-kB Tumor Expression Predicts Response and Survival in Irinotecan-Refractory Metastatic Colorectal Cancer Treated With Cetuximab-Irinotecan Therapy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PATH.3034

1 reference

1 November 2017

1 reference